<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35989844</PMID><DateRevised><Year>2022</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Coexistence of Pancytopenia and Myositis After Developing COVID-19.</ArticleTitle><Pagination><StartPage>e26978</StartPage><MedlinePgn>e26978</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e26978</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.26978</ELocationID><Abstract><AbstractText>COVID-19 causes not only acute but also subacute medical conditions during the clinical course. COVID-19 causes severe inflammatory conditions; therefore, patients may develop long-term complications. Among patients with acute COVID-19, some patients can experience persistent symptoms, such as fatigue, joint pain, and smell and taste abnormalities, known as the long COVID-19 syndrome. The symptoms can be severe and require continuous medical care. Patients with severe clinical courses of COVID-19 may have critical symptoms again after the cure of the acute infections, especially among older patients. We encountered a case of neutropenia and myositis one month after contracting COVID-19. An 89-year-old man presented to our hospital with acute-onset systemic muscle pain and difficulty in movement and speaking. The patient had neutropenia and myositis with an extremely high level of immunoglobulin G caused by COVID-19. A granulocyte colony-stimulating factor could be effective for treating neutropenia. Besides, prednisolone was effective for treating myositis. In community hospitals, after developing COVID-19, appropriate history taking and physical examination should be performed in older patients with ambiguous symptoms, as they might have critical medical conditions such as neutropenia and myositis. The appropriate diagnosis and treatments of older patients with the complications of COVID-19 should be performed.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022, Okayasu et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Okayasu</LastName><ForeName>Tatsuhiko</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Family Medicine, International University of Health and Welfare, Tokyo, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohta</LastName><ForeName>Ryuichi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Communiy Care, Unnan City Hospital, Unnan, Shimane, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Igarashi</LastName><ForeName>Mari</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Education, International University of Health and Welfare, Tokyo, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurita</LastName><ForeName>Yasuo</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Cardiology, International University of Health and Welfare, Tokyo, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayakawa</LastName><ForeName>Miho</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Education, International University of Health and Welfare, Tokyo, JPN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sano</LastName><ForeName>Chiaki</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Community Medicine Management, Shimane University Faculty of Medicine, Izumo, JPN.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">autoantibody myositis</Keyword><Keyword MajorTopicYN="N">community hospitals</Keyword><Keyword MajorTopicYN="N">covid-19</Keyword><Keyword MajorTopicYN="N">idiopathic neutropenia</Keyword><Keyword MajorTopicYN="N">japan</Keyword><Keyword MajorTopicYN="N">rural</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>22</Day><Hour>3</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35989844</ArticleId><ArticleId IdType="pmc">PMC9385165</ArticleId><ArticleId IdType="doi">10.7759/cureus.26978</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>COVID-19 presents high risk to older persons. Applegate WB, Ouslander JG. J Am Geriatr Soc. 2020;68:681.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7166412</ArticleId><ArticleId IdType="pubmed">32154911</ArticleId></ArticleIdList></Reference><Reference><Citation>Effect of emergency declaration for the COVID &#x2212;19 outbreak in Tokyo, Japan in the first two weeks: medRxiv.  [
Apr;
2020 
];Kurita J, Sugawara T, Ohkusa Y. https://www.medrxiv.org/content/10.1101/2020.04.16.20067447v2.full.pdf 2020 </Citation></Reference><Reference><Citation>Progression of COVID-19 from urban to rural areas in the United States: a spatiotemporal analysis of prevalence rates. Paul R, Arif AA, Adeyemi O, Ghosh S, Han D. J Rural Health. 2020;36:591&#x2013;601.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361905</ArticleId><ArticleId IdType="pubmed">32602983</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID- 19: a global challenge with old history, epidemiology and progress so far. Khan M, Adil SF, Alkhathlan HZ, Tahir MN, Saif S, Khan M, Khan ST. Molecules. 2020;26:39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7795815</ArticleId><ArticleId IdType="pubmed">33374759</ArticleId></ArticleIdList></Reference><Reference><Citation>Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. Ayoubkhani D, Bermingham C, Pouwels KB, et al. BMJ. 2022;377:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Huang L, Yao Q, Gu X, et al. Lancet. 2021;398:747&#x2013;758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Temporal trends in primary care-recorded self-harm during and beyond the first year of the COVID-19 pandemic: Time series analysis of electronic healthcare records for 2.8 million patients in the Greater Manchester Care Record. Steeg S, Bojani&#x107; L, Tilston G, et al. EClinicalMedicine. 2021;41:101175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8557994</ArticleId><ArticleId IdType="pubmed">34746726</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiology of Covid-19 in a long-term care facility in King county, Washington. McMichael TM, Currie DW, Clark S, et al. N Engl J Med. 2020;382:2005&#x2013;2011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7121761</ArticleId><ArticleId IdType="pubmed">32220208</ArticleId></ArticleIdList></Reference><Reference><Citation>Prolonged self-resolving neutropenia following asymptomatic COVID-19 infection. Desai S, Quraishi J, Citrin D. Cureus. 2021;13:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8287839</ArticleId><ArticleId IdType="pubmed">34290941</ArticleId></ArticleIdList></Reference><Reference><Citation>New onset of autoimmune diseases following COVID-19 diagnosis. Gracia-Ramos AE, Martin-Nares E, Hern&#xe1;ndez-Molina G. Cells. 2021;10:3592.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8700122</ArticleId><ArticleId IdType="pubmed">34944099</ArticleId></ArticleIdList></Reference><Reference><Citation>Covid-19: what new variants are emerging and how are they being investigated? Mahase E. BMJ. 2021;372:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">33462092</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 infection in the Veterans Health Administration: gender-specific racial and ethnic differences. Upchurch DM, Wong MS, Yuan AH, Haderlein TP, McClendon J, Christy A, Washington DL. Womens Health Issues. 2022;32:41&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8486675</ArticleId><ArticleId IdType="pubmed">34702652</ArticleId></ArticleIdList></Reference><Reference><Citation>Febrile neutropenia due to COVID-19 in an immunocompetent patient. Devi YM, Sehrawat A, Panda PK, Nath UK. BMJ Case Rep. 2021;14:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8074537</ArticleId><ArticleId IdType="pubmed">33893137</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 disease and dermatomyositis: a mini-review. Qian J, Xu H. Front Immunol. 2021;12:747116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8792859</ArticleId><ArticleId IdType="pubmed">35095837</ArticleId></ArticleIdList></Reference><Reference><Citation>Neutrophils in COVID-19. Reusch N, De Domenico E, Bonaguro L, Schulte-Schrepping J, Ba&#xdf;ler K, Schultze JL, Aschenbrenner AC. Front Immunol. 2021;12:652470.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8027077</ArticleId><ArticleId IdType="pubmed">33841435</ArticleId></ArticleIdList></Reference><Reference><Citation>Post-COVID-19 severe neutropenia. Bouslama B, Pierret C, Khelfaoui F, Bellann&#xe9;-Chantelot C, Donadieu J, H&#xe9;ritier S. Pediatr Blood Cancer. 2021;68:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7883096</ArticleId><ArticleId IdType="pubmed">33355971</ArticleId></ArticleIdList></Reference><Reference><Citation>What resources do elderly people choose for managing their symptoms? Clarification of rural older people's choices of help-seeking behaviors in Japan. Ohta R, Sato M, Ryu Y, Kitayuguchi J, Maeno T, Sano C. BMC Health Serv Res. 2021;21:640.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8254357</ArticleId><ArticleId IdType="pubmed">34217269</ArticleId></ArticleIdList></Reference><Reference><Citation>Challenges and solutions in the continuity of home care for rural older people: a thematic analysis. Ohta R, Ryu Y, Kitayuguchi J, Gomi T, Katsube T. Home Health Care Serv Q. 2020;39:126&#x2013;139.</Citation><ArticleIdList><ArticleId IdType="pubmed">32174235</ArticleId></ArticleIdList></Reference><Reference><Citation>Fears related to COVID-19 among rural older people in Japan. Ohta R, Ryu Y, Sano C. Healthcare (Basel) 2021;9:524.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146122</ArticleId><ArticleId IdType="pubmed">33946911</ArticleId></ArticleIdList></Reference><Reference><Citation>Impact of COVID-19 on the analytical diagnosing ability of family medicine residents. Ohta R, Nishikura N, Sano C. J Gen Fam Med. 2021;22:109&#x2013;110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7921335</ArticleId><ArticleId IdType="pubmed">33717790</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>